Page last updated: 2024-10-31

metyrapone and Ischemia

metyrapone has been researched along with Ischemia in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nilsson, UA1
Olsson, LI1
Thor, H1
Moldeus, P1
Bylund-Fellenius, AC1
Mertens, HG1
Lurati, M1
Schimrigk, K1
Führ, J1
Hofer, S1
Pette, D1

Other Studies

2 other studies available for metyrapone and Ischemia

ArticleYear
Detection of oxygen radicals during reperfusion of intestinal cells in vitro.
    Free radical biology & medicine, 1989, Volume: 6, Issue:3

    Topics: Animals; Cell Membrane; Cell Membrane Permeability; Cell Survival; Cytochrome P-450 Enzyme System; D

1989
[Energy providing metabolism of muscles in periodic paralysis].
    Klinische Wochenschrift, 1969, May-01, Volume: 47, Issue:9

    Topics: Adult; Blood Glucose; Dexamethasone; Diet, Sodium-Restricted; Dietary Carbohydrates; Glucocorticoids

1969